Journal
ANNALS OF NEUROLOGY
Volume 76, Issue 5, Pages 727-737Publisher
WILEY
DOI: 10.1002/ana.24265
Keywords
-
Categories
Funding
- NIH National Institute of Neurological Disorders and Stroke (NINDS) [R01NS063022]
- Schulze Family Foundation
- Mayo Clinic Center for Individualized Medicine
- NIH NINDS [U54NS0657, R01NS075764, R01NS072248]
- Muscular Dystrophy Association
- NIH National Cancer Institute [U10CA37404-27, CA15083]
Ask authors/readers for more resources
ObjectiveMutations in Charcot-Marie-Tooth disease (CMT) genes are the cause of rare familial forms of polyneuropathy. Whether allelic variability in CMT genes is also associated with common forms of polyneuropathyconsidered acquired in medical parlanceis unknown. Chemotherapy-induced peripheral neuropathy (CIPN) occurs commonly in cancer patients and is individually unpredictable. We used CIPN as a clinical model to investigate the association of non-CMT polyneuropathy with CMT genes. MethodsA total of 269 neurologically asymptomatic cancer patients were enrolled in the clinical trial Alliance N08C1 to receive the neurotoxic drug paclitaxel, while undergoing prospective assessments for polyneuropathy. Forty-nine CMT genes were analyzed by targeted massively parallel sequencing of genomic DNA from patient blood. ResultsA total of 119 (of 269) patients were identified from the 2 ends of the polyneuropathy phenotype distribution: patients that were most and least susceptible to paclitaxel polyneuropathy. The CMT gene PRX was found to be deleteriously mutated in patients who were susceptible to CIPN but not in controls (p=8 x 10(-3)). Genetic variation in another CMT gene, ARHGEF10, was highly significantly associated with CIPN (p=5 x 10(-4)). Three nonsynonymous recurrent single nucleotide variants contributed to the ARHGEF10 signal: rs9657362, rs2294039, and rs17683288. Of these, rs9657362 had the strongest effect (odds ratio=4.8, p=4 x 10(-4)). InterpretationThe results reveal an association of CMT gene allelic variability with susceptibility to CIPN. The findings raise the possibility that other acquired polyneuropathies may also be codetermined by genetic etiological factors, of which some may be related to genes already known to cause the phenotypically related Mendelian disorders of CMT. Ann Neurol 2014;76:727-737
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available